David Hutton

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.

During AAO 2020, Cathy G. Cohen, MHSA, CAE, AAO vice president for governmental affairs, offered some optimism for the future of health care under the Biden administration.

The US Food and Drug Administration has issued an emergency use authorization for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results.

Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.

Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.

The eye health community is sounding the alarm that the COVID-19 pandemic could worsen the epidemic of children at risk of nearsightedness.

A Phase 3 clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

Pfizer Inc. and BioNTech SE this week announced their mRNA-based coronavirus vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without evidence of infection.

American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's virtual annual meeting — kicking off Nov. 13-15.

Congress paused Medicare sequester cuts to offer relief amid the pandemic. Now, the leaders of the American Medical Association, American Hospital Association, American Health Care Association, and National Association for Home Care & Hospice are urging congressional leadership to keep the pause in place.

The ophthalmic community is mourning the loss of Alan S. Crandall, MD, a fixture at the John A. Moran Eye Center at the University of Utah for nearly four decades.

Queen Elizabeth II and the Countess of Wessex on Thursday marked World Sight Day during a video chat with the International Agency for the Prevention of Blindness and eye health professionals.

Through donations and activism, industry leaders are educating the public on the importance of eye health as a survey finds many people understand importance of exams, but don’t always seek treatment.

Selections from Through the Looking Glasses: Stories About Seeing Clearly will be read in a virtual setting to increase awareness of the importance of seeing clearly.

Canadian researchers have found that wearing a mask can have a significant impact on the spread of COVID-19.

Primary care has yet to regain the strength it had before the COVID-19 pandemic, according to a study released recently by the Larry A. Green Center, a research organization, in collaboration with the Primary Care Collaborative.

The U.S. Department of Health and Human Services has announced $20 billion in new funding for providers on the frontlines of the coronavirus pandemic.

A French kindergarten teacher has lost his job after the parents of a child complained about his appearance, which includes multiple face tattoos, including the sclera of his eyes, which have been turned to black by the ink. Scleral tattoos pose a serious threat to eye health, and could be a challenge for ophthalmologists treating these patients.

In an effort to help ophthalmologists bring patients back to the office, a global ophthalmic medical device manufacturer has unveiled a line of patient personal protection equipment packs.

Physicians struggling under the strains of the pandemic often think they cannot seek professional counseling, as burnout is at an all-time high and more than 50% of ophthalmologists saw their incomes drop by more than 50%.

According to an analysis of Medicaid enrollment data during the coronavirus disease 2019 (COVID-19) pandemic, there has been an increase in enrollment during the crisis. This shift is likely to have a ripple effect throughout the healthcare landscape, including ophthalmology.

A survey by the American Association of Pediatric Ophthalmology and Strabismus found that the COVID-19 pandemic could leave some pediatric ophthalmology practices highly strained, possibly beyond repair.

Investigators with the Texas Tech University Health Sciences Center Department of Ophthalmology and Visual Sciences have filed a US patent for a novel peptide that uses selenium as a catalyst to target vulnerable areas of coronaviruses, including COVID-19.

In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.

Investigators conducted a slit lamp biomicroscope experiment, simulating a patient undergoing an eye examination and then spontaneously coughing, spraying droplets.

To prepare students and their families for the new school year, the American Academy of Ophthalmology is sharing a back-to-online school checklist to help prevent digital eye strain.

ICYMI: Alice Epitropoulos, MD, FACS, speaks on "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.

The FDA this week granted the fourth Orphan Drug Designation for a novel gene therapy product candidate (OCU400, Ocugen Inc.) in the treatment of PDE6B gene mutation-associated retinal diseases.

Dilraj Grewal, MD, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during ASRS 2020.